Inflammatory Breast Cancer Research Foundation
Committed To Finding The Cause!
Focusing on Research and Awareness
Home
About Us
IBC 21st Century Research
Photos of IBC
Donations & Fund Raising
Store
Contact Us
Protected: board
This post is password protected. To view it please enter your password below:
Password:
Updating...
Site Search
Newsletter Signup
Email Privacy Policy
Brochures and Bookmarks
Contact Us
Discussions and Newsletter
Frequently Asked Questions
Inflammatory Breast Cancer Research Foundation BioBank
Grants Awarded
IBC in History
IBC in Our Own Words
IBC in the Media
IBC Mini Symposium
IBC Slide Presentation
National Cancer Institute Dictionary of Cancer Terms
National Cancer Institute Drug Dictionary
NCCN® Clinical Practice Guidelines For Inflammatory Breast Cancer
Selected Additional Resources
Log in
Breast Cancer Clinical Trials
Multicentric Randomized Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus 5-fluorouracil, Leucovorin, Irinotecan and Oxaliplatin (mFolfirinox) in Patients With Resected Pancreatic Adenocarcinoma
February 1, 2012
A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer
February 1, 2012
Donor Atorvastatin Calcium in Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Blood Stem Cell Transplant
January 31, 2012
A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer
January 30, 2012
Digital Breast Tomosynthesis Versus Digital Mammography: A National Multicenter Trial
January 29, 2012
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer
January 27, 2012
Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms
January 27, 2012
A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis
January 26, 2012
Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer
January 25, 2012
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
January 25, 2012